Mutual of America Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.7M | Buy |
201,432
+454
| +0.2% | +$97.7K | 0.49% | 24 |
|
|
2026
Q1 | $43.7M | Sell |
200,978
-2,114
| -1% | -$469K | 0.5% | 18 |
|
|
2025
Q4 | $46.4M | Sell |
203,092
-2,047
| -1% | -$466K | 0.49% | 19 |
|
|
2025
Q3 | $47.5M | Sell |
205,139
-11,465
| -5% | -$2.33M | 0.5% | 21 |
|
|
2025
Q2 | $40.2M | Sell |
216,604
-3,730
| -2% | -$693K | 0.43% | 24 |
|
|
2025
Q1 | $46.2M | Sell |
220,334
-6,930
| -3% | -$1.35M | 0.53% | 23 |
|
|
2024
Q4 | $40.4M | Sell |
227,264
-6,543
| -3% | -$1.2M | 0.43% | 24 |
|
|
2024
Q3 | $46.2M | Sell |
233,807
-5,748
| -2% | -$1.07M | 0.49% | 23 |
|
|
2024
Q2 | $41.1M | Sell |
239,555
-3,633
| -1% | -$602K | 0.45% | 23 |
|
|
2024
Q1 | $44.3M | Sell |
243,188
-8,270
| -3% | -$1.43M | 0.48% | 24 |
|
|
2023
Q4 | $39M | Sell |
251,458
-11,808
| -4% | -$1.72M | 0.45% | 23 |
|
|
2023
Q3 | $39.2M | Sell |
263,266
-7,404
| -3% | -$1.09M | 0.48% | 23 |
|
|
2023
Q2 | $36.5M | Buy |
270,670
+249
| +0.1% | +$36.5K | 0.41% | 27 |
|
|
2023
Q1 | $43.1M | Sell |
270,421
-141
| -0.1% | -$21.6K | 0.51% | 22 |
|
|
2022
Q4 | $43.7M | Buy |
270,562
+6,930
| +3% | +$1.06M | 0.54% | 19 |
|
|
2022
Q3 | $35.4M | Buy |
263,632
+3,850
| +1% | +$552K | 0.48% | 21 |
|
|
2022
Q2 | $39.8M | Buy |
259,782
+4,178
| +2% | +$638K | 0.51% | 20 |
|
|
2022
Q1 | $41.4M | Buy |
255,604
+2,497
| +1% | +$363K | 0.44% | 22 |
|
|
2021
Q4 | $34.3M | Buy |
253,107
+332
| +0.1% | +$39.2K | 0.35% | 30 |
|
|
2021
Q3 | $27.3M | Buy |
252,775
+1,365
| +0.5% | +$156K | 0.27% | 44 |
|
|
2021
Q2 | $28.3M | Buy |
251,410
+1,762
| +0.7% | +$198K | 0.28% | 41 |
|
|
2021
Q1 | $27M | Buy |
249,648
+4,488
| +2% | +$480K | 0.28% | 42 |
|
|
2020
Q4 | $26.3M | Sell |
245,160
-6,933
| -3% | -$666K | 0.3% | 37 |
|
|
2020
Q3 | $22.1M | Sell |
252,093
-12,428
| -5% | -$1.17M | 0.3% | 44 |
|
|
2020
Q2 | $26M | Sell |
264,521
-38,301
| -13% | -$3.37M | 0.37% | 37 |
|
|
2020
Q1 | $23.1M | Buy |
302,822
+13,048
| +5% | +$1.11M | 0.39% | 33 |
|
|
2019
Q4 | $25.7M | Sell |
289,774
-1,025
| -0.4% | -$85.1K | 0.33% | 38 |
|
|
2019
Q3 | $22M | Buy |
290,799
+4,378
| +2% | +$300K | 0.31% | 40 |
|
|
2019
Q2 | $20.8M | Buy |
286,421
+18,369
| +7% | +$1.44M | 0.29% | 41 |
|
|
2019
Q1 | $21.6M | Sell |
268,052
-18,347
| -6% | -$1.5M | 0.31% | 38 |
|
|
2018
Q4 | $26.4M | Buy |
286,399
+19,027
| +7% | +$1.67M | 0.44% | 30 |
|
|
2018
Q3 | $25.3M | Sell |
267,372
-13,854
| -5% | -$1.31M | 0.36% | 35 |
|
|
2018
Q2 | $26.1M | Sell |
281,226
-8,954
| -3% | -$874K | 0.39% | 30 |
|
|
2018
Q1 | $27.5M | Buy |
290,180
+1,698
| +0.6% | +$187K | 0.42% | 26 |
|
|
2017
Q4 | $27.9M | Buy |
288,482
+15,916
| +6% | +$1.5M | 0.43% | 29 |
|
|
2017
Q3 | $24.2M | Buy |
272,566
+20,389
| +8% | +$1.55M | 0.4% | 28 |
|
|
2017
Q2 | $18.3M | Buy |
252,177
+3,428
| +1% | +$230K | 0.32% | 41 |
|
|
2017
Q1 | $16.2M | Buy |
248,749
+9,313
| +4% | +$586K | 0.29% | 43 |
|
|
2016
Q4 | $15M | Buy |
239,436
+19,512
| +9% | +$1.19M | 0.28% | 46 |
|
|
2016
Q3 | $13.9M | Buy |
219,924
+15,296
| +7% | +$990K | 0.28% | 48 |
|
|
2016
Q2 | $12.7M | Buy |
204,628
+23,522
| +13% | +$1.43M | 0.27% | 50 |
|
|
2016
Q1 | $10.3M | Sell |
181,106
-1,218
| -0.7% | -$67.9K | 0.23% | 64 |
|
|
2015
Q4 | $10.8M | Sell |
182,324
-1,592
| -0.9% | -$91.7K | 0.24% | 62 |
|
|
2015
Q3 | $10M | Sell |
183,916
-4,451
| -2% | -$290K | 0.24% | 61 |
|
|
2015
Q2 | $12.7M | Buy |
188,367
+11,307
| +6% | +$738K | 0.28% | 52 |
|
|
2015
Q1 | $10.4M | Buy |
177,060
+4,959
| +3% | +$300K | 0.23% | 70 |
|
|
2014
Q4 | $11.3M | Buy |
172,101
+1,585
| +0.9% | +$99.9K | 0.25% | 54 |
|
|
2014
Q3 | $9.85M | Buy |
170,516
+2,897
| +2% | +$161K | 0.24% | 56 |
|
|
2014
Q2 | $9.46M | Sell |
167,619
-4,253
| -2% | -$223K | 0.22% | 57 |
|
|
2014
Q1 | $8.83M | Sell |
171,872
-8,391
| -5% | -$424K | 0.21% | 66 |
|
|
2013
Q4 | $9.52M | Buy |
180,263
+20,425
| +13% | +$1M | 0.23% | 60 |
|
|
2013
Q3 | $7.15M | Sell |
159,838
-2,591
| -2% | -$115K | 0.2% | 83 |
|
|
2013
Q2 | $6.71M | Buy |
+162,429
| New | +$7.1M | 0.2% | 81 |
|
Other funds holding ABBV
Mutual of America Capital Management's ABBV Position: Q2 2026 in Review
Mutual of America Capital Management increased its AbbVie (ABBV) stake by 0.23% in Q2 2026, buying an estimated $97.7K and bringing the position to 201,432 shares worth $50.7M. The position accounts for 0.49% of the portfolio, ranked #24.
Mutual of America Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 3,393 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Mutual of America Capital Management held 201,432 shares of AbbVie worth $50.7M as of Q2 2026.
- Mutual of America Capital Management bought 454 AbbVie shares in Q2 2026, an estimated $97.7K.
- AbbVie made up 0.49% of Mutual of America Capital Management's portfolio in Q2 2026, its #24 holding.
- Mutual of America Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 3,393 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.